Alnylam Pharmaceuticals
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-273.40190.9880.0443.42
Price/Sales ratio
23.3417.3613.3910.61
Earnings per Share (EPS)
$-1.64$2.35$5.61$10.34

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-19.99-27.25-7.81-23.43-9.63-14.20-17.41-23.55-25.56-54.30-22.10-14.20
Price/Sales ratio
142.50192.3967.95127.9597.9057.2630.3223.7927.8713.0724.0957.26
Price/Book Value ratio
7.696.253.486.515.638.7414.7034.14-182.77-108.35-158.008.74
Price/Cash Flow ratio
-43.49-41.80-10.41-30.05-13.03-45.19-24.30-31.30-53.42229.54-46.18-45.19
Price/Free Cash Flow ratio
-41.26-39.12-8.60-23.62-10.63-30.06-21.80-27.97-47.15569.99-40.76-30.06
Price/Earnings Growth ratio
-0.080.94-0.20-1.78-0.24-1.992.176.75-0.870.870.71-0.24
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
100%100%100%85.13%97.59%88.59%84.16%83.40%83.72%83.02%83.72%88.59%
Operating Profit Margin
-800.97%-720.26%-900.33%-556.19%-1087.56%-427.49%-168.09%-83.93%-75.67%-15.43%-75.67%-1087.56%
Pretax Profit Margin
-792.31%-705.82%-869.62%-545.94%-1015.47%-402.84%-173.60%-100.93%-108.63%-23.71%-108.63%-1015.47%
Net Profit Margin
-712.79%-705.82%-869.62%-545.94%-1016.57%-403.23%-174.14%-101.01%-109.03%-24.07%-109.03%-1016.57%
Effective Tax Rate
10.03%8.58%5.71%5.21%-0.10%-0.09%-0.31%-0.07%-0.36%-1.55%-0.36%-0.09%
Return on Assets
-33.38%-20.92%-32.47%-24.60%-48.35%-36.99%-25.19%-23.40%-31.89%-11.49%-31.89%-48.35%
Return On Equity
-38.49%-22.93%-44.56%-27.78%-58.48%-61.59%-84.45%-144.98%714.91%199.52%-1287.80%-61.59%
Return on Capital Employed
-43.25%-23.40%-39.67%-27.83%-61.16%-65.29%-36.34%-28.90%-28.25%-9.85%-28.25%-61.16%
Liquidity Ratios
Current Ratio
7.8217.805.1012.236.684.863.61N/AN/AN/A3.504.86
Quick Ratio
7.1511.155.138.994.881.751.832.303.332.983.163.16
Cash ratio
6.1510.511.003.251.730.570.440.681.120.831.121.12
Days of Sales Outstanding
288.3073.69180.59138.0391.4171.4475.8485.8483.7265.4383.7271.44
Days of Inventory outstanding
N/AN/AN/A0.004.87K820.64431.63319.57278.82104.82278.82820.64
Operating Cycle
N/AN/AN/A138.034.96K892.08507.48405.41362.55170.26299.47892.08
Days of Payables Outstanding
N/AN/AN/A774.2612.09K726.50243.01191.23212.0865.28212.08726.50
Cash Conversion Cycle
N/AN/AN/A-636.23-7.12K165.58264.47214.18150.46104.98-59.61-7.12K
Debt Ratios
Debt Ratio
N/AN/A0.110.010.010.110.060.510.650.621.040.01
Debt Equity Ratio
N/AN/A0.160.010.020.190.203.16-14.59-10.86-23.410.19
Long-term Debt to Capitalization
N/AN/A0.140.010.020.160.150.751.071.101.140.02
Total Debt to Capitalization
N/AN/A0.140.010.020.160.160.761.071.101.130.02
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/A-9.80N/AN/AN/A-5.03N/A
Cash Flow to Debt Ratio
N/AN/A-2.05-12.75-18.75-1.00-3.00-0.34-0.230.04-0.40-18.75
Company Equity Multiplier
1.151.091.371.121.201.663.356.19-22.41-17.35-22.411.66
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-3.27-4.60-6.52-4.25-7.51-1.26-1.24-0.76-0.520.05-0.52-7.51
Free Cash Flow / Operating Cash Flow Ratio
1.051.061.201.271.221.501.111.111.130.401.131.50
Cash Flow Coverage Ratio
N/AN/A-2.05-12.75-18.75-1.00-3.00-0.34-0.230.04-0.40-18.75
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/A-46.18-17.30-13.431.89-12.89N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A